Christopher Burrell
Neurology · Huntington, WVNPI 1992361778
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AbbVie accounts for 81.0% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $936, more than ten times the $18 reported in 2023. That places this record below the midpoint for neurology clinicians in WV, where the typical reported total is $1,217.
Across 85 payments — averaging $15.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Neurocrine Biosciences, Inc.$55
- Lundbeck LLC$49
- Apellis Pharmaceuticals, Inc.$47
- Neurelis, Inc.$22
- Xeris Pharmaceuticals, Inc.$21
- plus $55 from 3 others
What the payments were for
- Food & beverage$1,309100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 72 | $1,061 |
| Neurocrine Biosciences, Inc. | 3 | $55 |
| Lundbeck LLC | 3 | $49 |
| Apellis Pharmaceuticals, Inc. | 2 | $47 |
| Neurelis, Inc. | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Acadia Pharmaceuticals Inc | 1 | $20 |
| Merz Pharmaceuticals, LLC | 1 | $19 |
| Biotissue Holdings Inc. | 1 | $16 |
How this compares
$1,309 in reported general payments places this provider in the 50th percentile of 93 neurology providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 11 | $135 |
Paid to pharmacies, not to this prescriber.
Other neurology in Huntington
- Paul FergusonHuntington$649K
- Ronald BareboHuntington$28K
- Lindsay LittlehalesHuntington$17K
- Samrina HanifHuntington$12K
- Suresh KumarHuntington$12K
- Kathryn ThorntonHuntington$3K
- Matthew BurtonHuntington$3K
- Justin NolteHuntington$2K
- Dharampreet SinghHuntington$971
- Gabrielle ConwayHuntington$914
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.